Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer - Contacts and Locations

Home

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

This study is ongoing, but not recruiting participants.

Study NCT00006471. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00006471

Locations


United States, Texas
	University of Texas - MD Anderson Cancer Center
	Houston, Texas, United States, 77030-4009

Sponsors and Collaborators

M.D. Anderson Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Bonnie S. Glisson, MD	M.D. Anderson Cancer Center